Oxytocin Peptide: Structure, Receptor Pharmacology and Research Overview

• Structure: 9 residues, a 6-residue ring closed by a Cys1–Cys6 disulfide bond, and a 3-residue tail ending in glycinamide.
• Identity: CAS 50-56-6; C₄₃H₆₆N₁₂O₁₂S₂; about 1007.2 g/mol (PubChem CID 439302).
• Receptor: the oxytocin receptor, a class A GPCR coupled mainly through G_q to phospholipase C-β and intracellular calcium release.
• Close relative: vasopressin differs at only two positions (3 and 8), and the two peptides can cross-react at each other’s receptors.
• Research areas: receptor pharmacology, uterine tissue and neuronal signaling, and animal models of social behavior. Human behavioral findings have faced replication concerns.

Oxytocin is a neuropeptide made in the hypothalamus and released from the posterior pituitary, as well as within the brain. Its classic physiological roles, studied for over a century, are contraction of uterine (myometrial) tissue and milk ejection. Since the 1990s it has also been studied for its role in social behavior in animal models.

In 1953 Vincent du Vigneaud’s group determined oxytocin’s amino acid sequence and synthesized it, the first synthesis of a polypeptide hormone. He received the 1955 Nobel Prize in Chemistry for this work. Synthetic oxytocin used in research today is made by solid-phase peptide synthesis.

Research-grade oxytocin is a laboratory reagent and is not the same thing as licensed hospital products containing oxytocin. See the Oxytocin 5mg product page for batch specifications.

Salt forms such as oxytocin acetate have different formulas and molecular weights, so a certificate of analysis should state which form was tested. The disulfide bond is essential to activity: reducing it opens the ring and changes how the peptide binds its receptor.

Oxytocin and arginine vasopressin (AVP) are closely related nine-residue peptides that likely arose from a common ancestral gene. They differ at just two positions:

Because they are so similar, each peptide can activate the other’s receptors at higher concentrations. Researchers use this cross-reactivity, and selective agonists and antagonists, to tell the two signaling systems apart. Mass spectrometry easily distinguishes the two: their masses differ by about 77 Da.

The oxytocin receptor is a class A (rhodopsin-like) G protein-coupled receptor. Its main pathway runs through G_q/11 to phospholipase C-β, producing inositol trisphosphate (IP₃) and diacylglycerol. IP₃ releases calcium from intracellular stores, which drives contraction in myometrial cells and other downstream responses. The receptor can also couple to G_i and activate MAP kinase pathways, depending on the cell type.

Receptor activity is shaped by cholesterol and magnesium in the membrane, and receptor numbers vary widely by tissue and physiological state. Gimpl and Fahrenholz reviewed these mechanisms in detail (Physiological Reviews, 2001).

For wider background on receptor signaling, see our overview of peptides in cell signaling research.

The studies below are summarized as research context only. They are not guidance for any use.

Animal models of social behavior

Some of the best-known oxytocin research comes from prairie voles, a monogamous rodent species. Young and Wang (Nature Neuroscience, 2004) reviewed evidence that oxytocin signaling in specific brain reward regions, together with vasopressin and dopamine, contributes to partner-preference formation in female prairie voles. Comparisons with non-monogamous meadow voles linked these differences to where the receptors are expressed in the brain.

Human behavioral research and its limits

Many human studies have tested whether oxytocin changes trust, social judgment or emotion recognition. Walum, Waldman and Young (Biological Psychiatry, 2016) reviewed this literature and concluded that many of the studies were statistically underpowered, which makes a large share of reported positive findings likely to be false positives. Findings in this area should be read with that caution.

Animal findings don’t automatically apply to humans, and the human behavioral literature remains unsettled.

Oxytocin’s small size makes it straightforward to characterize, but a few points matter:

• Identity: mass spectrometry should match about 1006.44 Da (monoisotopic) and rule out vasopressin and other close analogs.
• Purity: HPLC separates oxytocin from related impurities such as deamidated forms (Gln4 or Asn5) and peptides with an opened or rearranged disulfide.
• Disulfide integrity: the intact ring is required for activity, so methods should distinguish the cyclic peptide from its reduced form and from dimers.
• Salt form and content: the certificate should state the form tested (for example, free base or acetate), since this changes the peptide content per milligram.

See our guide to reading a peptide certificate of analysis.

Oxytocin is a small, well-characterized cyclic peptide with a long research history, from the first peptide hormone synthesis in 1953 to modern receptor pharmacology. Its close relationship with vasopressin, its G_q-coupled receptor, and its role in animal models of social behavior make it a standard tool in neuropeptide research. Careful analytical work, confirming identity, the intact disulfide and the salt form, keeps that research reproducible.

1. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiological Reviews. 2001;81(2):629–683. PubMed 11274341 · doi:10.1152/physrev.2001.81.2.629
2. Young LJ, Wang Z. The neurobiology of pair bonding. Nature Neuroscience. 2004;7:1048–1054. doi:10.1038/nn1327
3. Walum H, Waldman ID, Young LJ. Statistical and methodological considerations for the interpretation of intranasal oxytocin studies. Biological Psychiatry. 2016;79:251–257. PubMed 26210057
4. du Vigneaud V, et al. The synthesis of an octapeptide amide with the hormonal activity of oxytocin. Journal of the American Chemical Society. 1953;75:4879–4880. See also the 1955 Nobel Prize in Chemistry.
5. PubChem. Oxytocin (CID 439302). pubchem.ncbi.nlm.nih.gov

This article is for scientific and educational purposes. It summarizes published research and is not guidance for human or veterinary use. NuRev Peptides does not provide use instructions of any kind. Research-grade oxytocin is not equivalent to licensed products containing oxytocin.